| Drug Name |
Pemoline |
| Drug ID |
BADD_D01705 |
| Description |
In 2005, the Food and Drug Administration (FDA) withdrew approval for pemoline. In March 2005, Abbott Laboratories (Cylert marketer) had discontinued the production of Cylert arguing economic reasons. |
| Indications and Usage |
For treatment of Attention Deficit Hyperactivity Disorder (ADHD) |
| Marketing Status |
approved; illicit; investigational; withdrawn |
| ATC Code |
N06BA05 |
| DrugBank ID |
DB01230
|
| KEGG ID |
D00744
|
| MeSH ID |
D010389
|
| PubChem ID |
4723
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
51552-1286 |
| UNII |
7GAQ2332NK
|
| Synonyms |
Pemoline | Phenylisohydantoin | Phenoxazole | Tradon | Pemoline Compounds | Compounds, Pemoline | Pemoline Magnesium | Magnesium, Pemoline | Cylert | PemADD |
